Answers are grounded in this paper and cite their sources.
Identifies metabolites that predict glucose normalization in adults with prediabetes, indicating potential biomarkers for intervention effectiveness.
Introduction and Objective: We determined whether plasma metabolites are associated with response to lifestyle intervention (LI) in people with prediabetes. Methods: We studied 138 adults (76 Black, 62 White) with prediabetes who received LI for 5 years. Assessments included anthropometry, body fat, fasting and 2-hr plasma glucose, insulin sensitivity and secretion, and plasma metabolites (18 amino acids, 45 acylcarnitines, 54 ceramides/other sphingolipids) measured with LC-ms/ms. Results: In all 59 participants reverted to normal glucose regulation (NGR), 69 had persistent prediabetes, and 10 developed T2D during LI. In logistic regression, the baseline predictors of persistent prediabetes versus NGR after LI (odds ratio (OR) per 1-SD) were 2hPG (2.042 [1.322-3.156], P=0.0013); ratios of ceramide C18:0/C18:1 (1.937 [1.239 - 3.028], P=0.0038) and ceramide C18:0/C16:0 (1.580 [1.049-2.381], P=0.029); and octenoylcarnitine (C8:1) (1.918 [1.083 - 3.399], P=0.026), adjusted for age, sex and race (Table). The predictive baseline metabolites showed significant associations with adiposity, insulin sensitivity, and insulin secretion. Conclusion: In adults with prediabetes, higher baseline levels of 2hPG, octenoylcarnitine (C8:1), and stearic/oleic acid ceramide ratio (C18:0/C18:1) predicted persistent prediabetes versus reversion to normoglycemia following lifestyle intervention. Disclosure P. Asuzu: None. F.B. Stentz: None. N. Mandal: None. S. Dagogo-Jack: Consultant; Current; Abbott, Madrigal Pharmaceuticals, Inc., Merck & Co., Inc., Novo Nordisk.
No takes yet. Share an insight, caveat, or question.
ASUZU et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: